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Purpose: Blood-retinal barrier (BRB) breakdown and retinal edema are major complications of autoimmune uveitis and
could be related to deregulation of aquaporin (AQP) expression. We have therefore evaluated the expression of AQP1
and AQP4 on BRB cells during experimental autoimmune uveitis (EAU) in mice.
Methods: C57Bl6 mice were immunized with interphotoreceptor retinoid-binding protein (IRBP) peptide 1–16. The
disease was graded clinically, and double immunolabeling using glial fibrillary acidic protein (GFAP; a marker of disease
activity) and AQP1 or AQP4 antibodies was performed at day 28. AQP1 expression was also investigated in mouse retinal
pigment epithelium (RPE) cells (B6-RPE07 cell line) by reverse transcriptase PCR and western blot under basal and tumor
necrosis factor α (TNF-α)-stimulated conditions.
Results: In both normal and EAU retina, AQP1 and AQP4 expression were restricted to the photoreceptor layer and to
the Müller cells, respectively. Retinal endothelial cells never expressed AQP1. In vasculitis and intraretinal inflammatory
infiltrates, decreased AQP1 expression was observed due to the loss of photoreceptors and the characteristic radial labeling
of AQP4 was lost. On the other hand, no AQP4 expression was detected in RPE cells. AQP1 was strongly expressed by
choroidal endothelial cells, rendering difficult the evaluation of AQP1 expression by RPE cells in vivo. No major
differences were found between EAU and controls at this level. Interestingly, B6-RPE07 cells expressed AQP1 in vitro,
and TNF-α downregulated AQP1 protein expression in those cells.
Conclusions: Changes in retinal expression of AQP1 and AQP4 during EAU were primarily due to inflammatory lesions,
contrasting with major modulation of AQP expression in BRB detected in other models of BRB breakdown. However,
our data showed that TNF-α treatment strongly modulates AQP1 expression in B6-RPE07 cells in vitro.
Uveitis is an important cause of blindness worldwide and
affects predominantly patients in the working age group [1].
Uveitis can have an infectious etiology or may be autoimmune
due  to  autoreactive  lymphocyte  activation.  Experimental
autoimmune uveitis (EAU) is induced in susceptible animals
by immunization by retinal proteins or peptides. EAU displays
many characteristics of human autoimmune posterior uveitis,
with  the  formation  of  vitritis,  retinal  vasculitis,  and
chorioretinitis [2]. The blood-retinal barrier (BRB) is reported
to be severely affected during EAU [3]. This finding is of
interest as the major cause of visual loss in uveitis patients is
macular edema secondary to BRB disruption [4]. A better
understanding of how water flow is regulated during BRB
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disruption might thus contribute to the development of new
therapeutic strategies for the treatment of patients.
BRB is a functional entity that regulates water, solutes,
and ions fluxes into the retina. The inner BRB relies on to the
isolation of the retina by the tight junctions of retinal vascular
endothelial  cells  [5,6]  and  its  tightness  is  improved  by
extensions of Müller cells surrounding retinal blood vessels.
The outer BRB relies on the tight junctions of the retinal
pigmented  epithelial  (RPE)  cells,  which  impede  any
transcellular  flow,  and  on  ionic  pumps  and  channels  that
create  a  transepithelial  osmotic  gradient.  Under  normal
conditions water follows this gradient and flows from the
subretinal space to the choroidal space through the RPE cells
[7]. The exact mechanisms by which water molecules can
penetrate the hydrophobic cellular membrane of the RPE cells
remain  elusive.  Aquaporins  (AQPs),  a  family  of  water-
specific  membrane-channel  proteins,  could  be  good
candidates for this function [8]. Indeed, it has been reported
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4 1that human RPE cells express AQP1 [9]. However, earlier
studies reported a lack of expression of AQPs 1, 3, 4, and 5 in
human RPE in vivo, suggesting that RPE cells could transport
water by AQP-independent mechanisms [10]. On the other
hand, AQP4 expression by Müller cells has been consistently
described  by  several  groups  and  is  strongest  at  their
perivascular and perisynaptic membrane domains [11–13].
Moreover, Müller cells are thought to be responsible for the
dehydratation of the inner retina through a process called “K+
siphoning” [6,14]. This process relies on the co-expression of
Kir4.1 and AQP4 on Müller cells, which allows water to
follow  K+  from  perisynaptic  spaces  to  blood  vessels.
Interestingly, during endotoxin-induced uveitis, Kir4.1 and
AQP4 expression were differentially regulated on Müller cells
and the swelling characteristics of these cells were altered by
inflammation [15,16]. This finding strongly suggests that the
regulation of AQP expression on BRB cells could be critical
in the formation of macular edema during uveitis.
The  aim  of  this  study  was  to  investigate  in  vivo  the
possible modification of the AQP expression pattern on BRB
during EAU. In addition, we analyzed the expression of AQP1
in a mouse RPE cell line in vitro and its regulation by tumor
necrosis  factor  α  (TNF-α),  mimicking  the  intraocular
inflammation (IOI) condition.
METHODS
Induction  of  experimental  autoimmune  uveitis:  EAU  was
induced in C57/Bl6 mice (Iffa Credo, Brussels, Belgium) by
subcutaneous 50-µl injections into each thigh with 50 µg
(seven mice) or 100 µg (five mice) of peptide corresponding
to 1–16 human interphotoreceptor retinoid-binding protein
(IRBP;  GPTHLFQPSLVLDMA;  Sigma-Aldrich,  Saint-
Louis,  MO),  emulsified  in  complete  Freund’s  adjuvant
(supplemented with 2.5 mg/ml mycobacterium tuberculosis;
Becton Dickinson, Oxford, UK). The animals received an
additional 50-µl intraperitoneal injection of 1 µg of Bordetella
pertussis toxin on day 0 (Becton Dickinson). Animals were
used in agreement with the Association for Research in Vision
and Ophthalmology (ARVO) statement for the use of animals
in  ophthalmic  and  vision  research,  and  all  experimental
procedures were approved and performed in compliance with
the ethics committees of the Université Libre de Bruxelles,
Brussels, Belgium.
Ocular examination and clinical grading: Twenty-one and 28
days  after  immunization,  mice  were  submitted  to  ocular
examination following pupil dilatation and fitting of glass
coverslips using Vidisic gel (Tramedico, Temse, Belgium).
Mouse eyes were positioned in front of a surgical microscope
lamp. The onset and the severity of the observable disease
were graded according to Xu et al. [17]. Briefly, the onset of
the observable disease and its course thereafter were clinically
graded  on  a  scale  0–4  depending  on  the  degree  of
inflammatory lesions of the posterior segment of the eye,
considering vitritis, optic neuropathy, vasculitis, retinitis, and
retinal folds. As for the characterization of uveitis in human
patients (P. Koch, unpublished data), a distinction was made
between active an inactive inflammatory lesions in mouse
eyes during EAU (P. Koch, unpublished data). Classically, an
active phase occurs during uveitis in which inflammatory cells
invade the eye. In the case of posterior uveitis during this
active  phase,  fundus  examination  will  demonstrate  the
presence of active lesions, such as cells in the vitrous, and
inflammatory  lesions,  such  as  retinal  and  chorioretinal
granulomas,  retinal  vasculitis  (with  vessel  sheathings,
exudates, and hemorrhages), and papillitis. After treatment (or
sometimes after a spontaneous natural recovery), these active
lesions will give rise to scars or so-called inactive lesions. The
distinction between active and inactive lesions can generally
be made by fundus examination.
Tissue preparation and hematoxylin and eosin staining: After
4 weeks of immunization, animals were sacrificed by neck
dislocation, and eyes were enucleated. Eyes were immediately
fixed in 4% buffered formaldehyde, paraffin-embedded, and
sectioned (5-µm thick) at different levels, including in the
proximity of the optic nerve. Eye sections were stained with
hematoxylin and eosin (Sigma-Aldrich) for histopathological
evaluation,  and  pictures  were  taken  using  an  Axioplan  2
(Zeiss, Göttingen, Germany).
Antibodies  to  aquaporins:  Antibodies,  resulting  from
immunization  of  rabbits  using  a  synthetic  peptide
corresponding to amino acids 301–318 of mouse AQP4 or to
amino acids 245–279 of human AQP1 (this sequence is 100%
identical to mouse AQP1), were affinity purified and their
specificities  verified  by  western  blot  and
immunohistochemistry (data not shown).
Immunofluorescence  on  eye  sections:  Eye  sections  were
incubated  with  the  primary  antibody  (rabbit  polyclonal
affinity-purified anti-AQP1, dilution 1:400; rabbit polyclonal
affinity-purified  AQP4,  dilution  1:200;  and  a  mouse
monoclonal to glial fibrillary acidic protein (GFAP; dilution
1:500;  Millipore,  Billerica,  MA),  overnight  at  4  °C,  then
incubated  with  biotinylated  antirabbit  immunoglobulin  G
(IgG;  1:200;  GE  Healthcare,  Little  Chalfont,  UK),
streptavidin-cyanin2 (1:300; Jackson Immunoresearch, West
Grove, PA), and antimouse IgG coupled to cyanin3 (Jackson
Immunoresearch).  Cyanin2  and  cyanin3  are,  respectively,
green and red fluorochromes. Cell nuclei were stained with
Hoechst  (1:5,000;  Sigma-Aldrich).  Finally,  sections  were
mounted  using  FluorSaveTM  reagent  (Calbiochem,
Gibbstown, NJ). As negative controls sections were incubated
either  with  secondary  antibody  alone  or  with  anti-AQP
antibodies pre-adsorbed with the immunizing peptide in 100-
fold excess. Immunofluorescent pictures were taken using an
Axiocam MRc 5 fluorescent microscope (Zeiss).
Cell culture and cell proteins: Mouse RPE cells (B6-RPE07)
were grown in Dulbecco’s Modified Eagle Medium (DMEM)
containing 10% fetal calf serum, 100 IU/ml streptomycin–
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confluence, cells were treated for 24 h with 10 ng/ml TNF-α.
Cells were lysed in 0.4 ml NP-40 lysis buffer containing
50  mM  Tris-HCl  (pH  7.5),  150  mM  NaCl,  0.5%  NP-40,
50 mM NaF, 1 mM sodium orthovanadate, dithiothreitol, and
protease inhibitors (Complete EDTA free; Roche, Mannheim,
Germany). Cells were then scraped using a rubber scraper,
transferred to a tube, frozen in liquid nitrogen, centrifuged for
10 min at 15,000× g, and the supernatant containing the total
proteins was collected.
Reverse transciptase PCR: Total RNA from mouse RPE cells
(B6-RPE07 cell line) was extracted using the AURUMTM kit
(Bio-Rad, Hercules, CA). The quality of the total RNA was
verified  using  an  Experion  Automated  Electrophoresis
System  Bioanalyzer  (Bio-Rad),  and  1  µg  total  RNA  was
reverse transcribed using a Revert AidTM first-strand cDNA
synthesis  kit  (Fermentas,  St.  Leon-Rot,  Germany).  The
primers used for amplification of mouse cDNA were: sense
primer 5′-GCT GTC ATG TAC ATC ATC GCC CAG-3′
nucleotides (nt 472–495) and antisense primer 5′-AGG TCA
TTG CGG CCA AGT GAA T-3′ (nt 557–578) for AQP1
(GenBank NM_007472, amplicon 106 bp); and sense primer
5′-TGC ACC ACC AAC TGC TTA GC-3′ (nt 498–517) and
antisense primer 5′-GAT GCA GGG ATG ATG TTC T-3′ (nt
655–674)  for  glyceraldehyde  3-phosphate  dehydrogenase
(GAPDH; GenBank NM_008084, amplicon 177 bp). PCR
reactions were performed in a total volume of 20 µl containing
1 µl of cDNA, 0.5 U GoTaq DNA polymerase (Promega,
Madison, WI), 0.2 mM deoxy nucleotides (dNTP), 250 nM of
each primer, and 4 µl GoTaq Green buffer using an iCycler
System (Bio-Rad). PCR conditions were 94 °C for 3 min,
followed by 35 cycles of 30 s at 95 °C, 30 s at 60 °C, and 1
min at 72 °C. PCR products were submitted to electrophoresis
on a 1.5% agarose gel.
Western blot analysis: Total protein preparations were used,
and 5% β-mercaptoethanol was added to the sample buffer.
The samples were analyzed by sodium dodecyl sulfate PAGE,
using 12% polyacrylamide gels. Proteins were transferred to
polyvinyldiene  difluoride  membranes  and  immunolabeled
using the affinity-purified antibody to AQP1 and β-actin at a
1:500  dilution.  Bound  antibodies  were  detected  using  the
enhanced chemiluminescence western blotting reagents (GE
Healthcare).
Figure 1. Expression of aquaporin 1, aquaporin 4, and glial fibrillary acidic protein in normal mouse retina. Normal mouse retina was submitted
to hematoxylin and eosin staining (A), or immunofluorescent staining for aquaporin 1 (AQP1; B), aquaporin 4 (AQP4; C), and glial fibrillary
acidic protein (GFAP; D). ILM represents inner limiting membrane; GCL represents ganglion cell layer; IPL represents inner plexiform layer;
INL represents inner nuclear layer; OPL represents outer plexiform layer; ONL represents outer nuclear layer; OLM represents outer limiting
membrane; IS represents inner segments of the photoreceptors; OS represents outer segments of the photoreceptors; RPE represents retinal
pigmented epithelium. Magnification is 200×.
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Aquaporin  1,  aquaporin  4,  and  and  glial  fibrillar  acidic
protein expression in normal mouse retina: Normal mouse
retina has ten well identified histological layers (Figure 1A).
AQP1 is expressed in the outer nuclear layer and the inner
segment of the photoreceptors (Figure 1B). AQP4 is localized
in the Müller cells, from the outer limiting membrane (OLM)
to  the  inner  limiting  membrane  and  surrounding  the
perivascular processes with their endfeet (Figure 1C). Weak
GFAP expression is present at the endfeet of some inactivated
Müller cells (Figure 1D).
Disease  severity  and  histopathological  lesions:  EAU  was
induced in 12 mice. Two groups of mice received an injection
of either 50 µg (n=7) or 100 µg (n=5) of IRBP. Three and four
weeks  post  injection,  a  clinical  grading  was  performed
(described above) according to Xu et al. [17]. After 21 days
12 eyes out of 24 (50%) developed an IOI. In the group
injected  with  50  µg  IRBP,  eight  eyes  (57%)  had  a  score
between 1.7 and 2.6 on a scale of 4. In the group injected with
100 µg IRBP, four eyes (40%) had an IOI with a clinical
grading ranging from 0.4 to 1.9 on a scale of 4. After 28 days,
14 eyes (58%) out of 24 eyes developed an IOI. Among the
group (14 eyes) that received 50 µg IRBP, ten eyes (71%) had
an IOI: three eyes had a grade between 0.3 and 1.2 on a scale
of 4 and seven had a score ranging from 1.8 to 3.2 on a scale
of 4. Among the group (ten eyes) that received 100 µg IRBP,
four eyes (40%) had a grade between 0.8 and 2.2 on a scale
of 4. Figure 2 summarizes the proportion of inactive and active
lesions in both groups (50 µg and 100 µg IRBP) at 21 and 28
days post injection.
Histopathological analysis of EAU mouse eyes revealed
the presence of focal lesions, such as intraretinal inflammatory
infiltrate and retinal architectural disorganization with some
destruction of the RPE cell monolayer, vitritis, retinal folds in
the layers extending from the outer plexiform layer to the RPE,
and vasculitis characterized by various inflammatory cells
surrounding a congested and dilated retinal vessel (data not
shown).
Aquaporin 1, aquaporin 4, and glial fibrillary acidic protein
expressions  during  experimental  autoimmune  uveitis:  To
investigate the possible role of AQPs in the development of
inflammatory  retinal  edema,  the  expression  of  AQP1  and
AQP4  was  analyzed  during  EAU.  Changes  in  GFAP
expression, described during retinal inflammation and used as
a marker for disease activity [19,20], were also investigated
in our model of EAU. In control animals GFAP was mainly
located in the ganglion cell layer (Figure 1D), while in eyes
developing  intraocular  inflammation  GFAP  expression  is
located  in  activated  Müller  cells  and  retinal  glial  cells,
extending from the inner limiting membrane to the OLM
(Figure 3B and Figure 4B). This pattern of GFAP expression
was  consequently  used  as  an  indicator  of  intraocular
inflammation. In normal (Figure 1B) and EAU (Figure 3A)
retinas, AQP1 expression was restricted to the photoreceptor
layer with an intense staining in the outer nuclear layer and
the photoreceptor inner segments. In the inner retina, some
red blood cells inside the retinal capillaries were also positive
for  AQP1  (Figure  1B,  Figure  3A).  Strikingly,  retinal
endothelial cells did not express AQP1 in normal or EAU
retina, even on vasculitis lesions (Figure 1B, Figure 3A,D). In
focal retinal inflammatory lesion, AQP1 intensity was lower
due to the loss of photoreceptors (Figure 3G).
As in normal retina, AQP4 was expressed in Müller cells
in EAU retina (Figure 4A). The staining was still intense in
the ganglion cell layer, the outer plexiform layer and the OLM
(Figure 4A). However, in vasculitis (Figure 4D) and in retinal
Figure  2.  Clinical  grading  of
experimental  autoimmune  uveitis.
Experimental autoimmune uveitis was
induced by the subcutaneous injection
of  50  µg  or  100  µg  of  peptide
corresponding  to  1–16  human
interphotoreceptor  retinoid-binding
protein. The clinical grading of active
and inactive lesions was performed on a
scale of 0–4 at 21 and 28 days post-
injection as described in Methods.
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labeling of AQP4 observed in controls was lost.
We carefully examined AQP1 and AQP4 expression in
RPE cells, corresponding to the external BRB. In normal and
EAU retina, AQP4 immunofluorescent staining was totally
absent from the OLM of the RPE cell monolayer, suggesting
that AQP4 is not expressed in RPE cells (data not shown).
Choroidal endothelial cells strongly expressed AQP1, and no
differences  were  found  between  EAU  and  controls.  The
intensity of the AQP1 staining by endothelial cells and their
proximity  with  RPE  cells  render  the  evaluation  of  AQP1
expression by RPE cells in vivo difficult (Figure 5).
Expression of aquaporin 1 and aquaporin 4 by mouse retinal
pigmented epithelial cells in vitro (B6-RPE07 cell line): Due
to the critical role of RPE cells in the regulation of retinal water
content and their implication in the development of uveitis,
AQP1  expression  was  further  analyzed  in  the  recently
described  clone  B6-RPE07  which  has  a  morphology,
phenotype, and function similar to those of mouse RPE cells
in vivo [18]. Both reverse transcriptase PCR (Figure 6A) and
western blot (Figure 6B) revealed the expression of AQP1 in
Figure 3. Retinal expression of aquaporin 1 and glial fibrillary acidic protein during experimental autoimmune uveitis. The images illustrate
retina without specific lesions (A, B, and C), with vasculitis (D, E, and F) or with intraretinal inflammatory infiltrate (G, H, and I). Retina
was submitted to immunofluorescent staining for aquaporin 1 (AQP1; in green; A, D, and G), or to glial fibrillary acidic protein (GFAP; in red;
B, E, and H). Cell nuclei were stained with DAPI (blue). C, F, and I correspond to merged images. ILM represents inner limiting membrane;
OLM represents outer limiting membrane; and RPE represents retinal pigmented epithelium. Magnification is 60×.
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606Figure 4. Retinal expression of aquaporin 4 and glial fibrillary acidic protein during experimental autoimmune uveitis. The images illustrate
retina without specific lesions (A, B, and C), with vasculitis (D, E, and F) or with intraretinal inflammatory infiltrate (G, H, I, J, K, and L).
Retina was submitted to immunofluorescent staining for aquaporin 4 (AQP4; in green; A, D, G, and J), or to glial fibrillary acidic protein
(GFAP; in red; B, E, H, and K). Cell nuclei were stained with DAPI (in blue). C, F, I, and L correspond to merged images. ILM represents
inner limiting membrane; OLM represents outer limiting membrane; RPE represents retinal pigmented epithelium. Magnification is 60×.
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downregulatedAQP1 expression in those cells (Figure 6B).
DISCUSSION
BRB cells regulate water movement in the retina. In the inner
part of the BRB, water follows the osmotic-driven potassium
flow and is extruded through AQP4 channels expressed on
Müller cells. In the subretinal space, water also follows the
direction  of  the  osmotic  gradient  and  flows  to  the
choriocapillaries through the tight RPE cell monolayer. AQP
expression  on  RPE  cells  is  still  controversial  [21].
Furthermore,  the  mechanisms  responsible  for  water
accumulation in the retina during macular edema are still
poorly understood. Nevertheless, it is tempting to postulate
that modulation of AQP expression is involved in macular
edema formation, as shown in brain edema as well [22,23].
Concerning the expression of AQPs in retina, our data
confirm the expression of AQP4 in Müller cells [11] and
AQP1 in photoreceptors [24]. Furthermore, neither AQP1 nor
AQP4 expression was found on retinal vascular endothelial
cells. However, AQP1 expression was strongly expressed on
choroidal  vascular  endothelial  cells.  Interestingly,  we
additionally found that AQP1 and AQP4 expression patterns
moderately altered during EAU compared to control probably
because of retinal restructuring during EAU. These latter data
are consistent with the slightly reduced expression of AQP4
observed during endotoxin-induced uveitis [15]. In contrast,
modulation  of  retinal  AQP1  and  AQP4  expressions  was
observed  during  experimental  diabetes  [25];  AQP1
expression was induced on glial cells and in the innermost
retinal layers [25]. However, retinal vascular endothelial cells
did not express AQP1 or AQP4 [25]. The absence of AQP1
expression in retinal vascular endothelial cells is consistent
with  our  data  and  those  from  Verkman’s  group  [21].
Altogether, these data emphasize the role of Müller cells in
retinal  water  transport  and  suggest  that  AQPs  might  be
differentially regulated during uveitis and diabetes.
No  AQP4  expression  was  found  in  the  RPE  cells
monolayer under normal conditions or in EAU. Despite the
important  role  assigned  to  RPE  cells  in  BRB  water  flow
regulation,  the  possible  expression  of  the  AQPs  remains
Figure 5. Subretinal expression of aquaporin 1 during experimental autoimmune uveitis. Retina was submitted to immunofluorescent staining
for aquaporin 1 (green; A). Cell nuclei were stained with DAPI (blue, B). C corresponds to merge image. The arrow shows the cell nuclei of
the RPE cells monolayer. RPE represents retinal pigmented epithelium and CC represents choriocapillaris. Magnification is 400×.
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AQP1 expression in rat RPE cells but described a strong
AQP1 immunolabeling in the posterior pigmented epithelium
of the iris. In contrast, human RPE cells were reported to
express  AQP1  in  situ,  and  RPE  cells  in  primary  culture
continued to express AQP1, although the expression level was
significantly lower [9]. In the present work, we found that the
intense expression of AQP1 by choroidal endothelial cells
renders the analysis of AQP1 expression by RPE cells in vivo
difficult. Therefore, the expression of AQPs in RPE cells was
analyzed in vitro. Our data showed that mouse RPE cells in
vitro  express  AQP1  and  that  AQP1  expression  is
downregulated following TNF-α stimulation.
In  conclusion,  in  contrast  to  other  models  of  BRB
breakdown, major modulation of AQP1 and AQP4 retinal
expression were not found during EAU. Our data also indicate
that  AQP1  is  indeed  expressed  in  RPE  cells  and  is
Figure 6. Expression of aquaporin 1 in mouse B6-RPE07 cells. A:
The  presence  of  aquaporin  1  (AQP1)  and  glyceraldehyde  3-
phosphate  dehydrogenase  (GAPDH)  mRNA  expression  was
detected by reverse-transcriptase PCR using B6-RPE07 cell cDNA
(RPE), kidney cDNA (kidney) used as positive control, or nontarget
control (CT-). Molecular weight ladders are shown. B: Aquaporin 1
(AQP1) and β-actin (ßactin) protein expressions were detected by
western blot in B6-RPE07 cells treated without (Ct) or with 10 ng/
ml tumor necrosis factor (TNFα). The blot is representative of three
experiments performed using distinct cell preparations.
downregulated following TNF-α treatment. Furthermore, the
latter observation supports in vivo expression of AQP1.
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